BioSpace News Archive

Press Releases

Aclaris Therapeutics Completes Enrollment in Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis

March 18, 2026
·
6 min read
Press Releases

Arvinas Announces Positive Phase 1 Data for ARV-102 Showing Greater Than 50% LRRK2 Degradation in the CSF of Patients with Parkinson’s Disease Treated for 28 Days

March 18, 2026
·
10 min read
Press Releases

XORTX Announces Substitute Director Nominees for its Upcoming Annual and Special Meeting of Shareholders

March 18, 2026
·
9 min read
Press Releases

OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes with Urcosimod in Neuropathic Corneal Pain

March 18, 2026
·
6 min read
Press Releases

Paratek Pharmaceuticals Completes Combination with Radius Health, Expanding Its Multi-Product Specialty Commercial Platform

March 18, 2026
·
5 min read
Press Releases

MCI Capital Markets and AxialBridge to Deliver Integrated De-Risking and Capital Access Platform for Life Science Companies

Partnership to Provide Life Science Companies with Turnkey Solution for Award Winning Capital Market Access, Best-In-Class Regulatory Affairs Management, Clinical Trial Management Services, and Investor Engagement

March 18, 2026
·
4 min read
Press Releases

Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026

March 18, 2026
·
2 min read
Press Releases

Marvel Biosciences Receives Notice of Allowance for US Patent Application Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204

March 18, 2026
·
5 min read
Press Releases

Resverlogix Announces Delay in Filing of Annual Financial Statements, AIF, and MD&A

March 18, 2026
·
4 min read
Press Releases

Gain Therapeutics Presents Additional Clinical and Biomarker Data from Phase 1b Clinical Study of GT-02287 and Preclinical Data from Novel Chemical Series at AD/PD 2026

March 18, 2026
·
10 min read